Veradigm announces strategic investment in holmusk

Chicago--( business wire )--veradigm inc. (nasdaq: mdrx), formerly allscripts healthcare solutions, inc., announced today an investment in holmusk, a global behavioral health real-world evidence and data analytics company, as part of holmusk's $45 million series b financing round. the round was led by veradigm, with participation from current investors including heritas capital, health catalyst capital, novartis (drx capital), and northwell holdings, the venture investment arm of northwell health, as well as other previous investors.
MDRX Ratings Summary
MDRX Quant Ranking